Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2008 2
2009 4
2010 2
2011 3
2012 3
2013 1
2014 2
2015 7
2016 11
2017 5
2018 8
2019 11
2020 9
2021 6
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Alpha-synucleinopathies.
Alafuzoff I, Hartikainen P. Alafuzoff I, et al. Among authors: hartikainen p. Handb Clin Neurol. 2017;145:339-353. doi: 10.1016/B978-0-12-802395-2.00024-9. Handb Clin Neurol. 2017. PMID: 28987181 Review.
Incidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries.
Logroscino G, Piccininni M, Graff C, Hardiman O, Ludolph AC, Moreno F, Otto M, Remes AM, Rowe JB, Seelaar H, Solje E, Stefanova E, Traykov L, Jelic V, Rydell MT, Pender N, Anderl-Straub S, Barandiaran M, Gabilondo A, Krüger J, Murley AG, Rittman T, van der Ende EL, van Swieten JC, Hartikainen P, Stojmenovic GM, Mehrabian S, Benussi L, Alberici A, Dell'Abate MT, Zecca C, Borroni B; FRONTIERS group. Logroscino G, et al. Among authors: hartikainen p. JAMA Neurol. 2023 Mar 1;80(3):279-286. doi: 10.1001/jamaneurol.2022.5128. JAMA Neurol. 2023. PMID: 36716024 Free PMC article.
Grey matter atrophy in patients with benign multiple sclerosis.
Niiranen M, Koikkalainen J, Lötjönen J, Selander T, Cajanus A, Hartikainen P, Simula S, Vanninen R, Remes AM. Niiranen M, et al. Among authors: hartikainen p. Brain Behav. 2022 Jul;12(7):e2679. doi: 10.1002/brb3.2679. Epub 2022 Jun 28. Brain Behav. 2022. PMID: 35765699 Free PMC article.
Modifiable potential risk factors in familial and sporadic frontotemporal dementia.
Soppela H, Katisko K, Gadola Y, Krüger J, Hartikainen P, Alberici A, Benussi A, Koivisto A, Haapasalo A, Remes AM, Borroni B, Solje E. Soppela H, et al. Among authors: hartikainen p. Ann Clin Transl Neurol. 2022 Aug;9(8):1195-1205. doi: 10.1002/acn3.51619. Epub 2022 Jun 29. Ann Clin Transl Neurol. 2022. PMID: 35767471 Free PMC article.
CACNA1S Variant Associated With a Myalgic Myopathy Phenotype.
Periviita V, Palmio J, Jokela M, Hartikainen P, Vihola A, Rauramaa T, Udd B. Periviita V, et al. Among authors: hartikainen p. Neurology. 2023 Oct 31;101(18):e1779-e1786. doi: 10.1212/WNL.0000000000207639. Epub 2023 Sep 7. Neurology. 2023. PMID: 37679049
Detecting frontotemporal dementia syndromes using MRI biomarkers.
Bruun M, Koikkalainen J, Rhodius-Meester HFM, Baroni M, Gjerum L, van Gils M, Soininen H, Remes AM, Hartikainen P, Waldemar G, Mecocci P, Barkhof F, Pijnenburg Y, van der Flier WM, Hasselbalch SG, Lötjönen J, Frederiksen KS. Bruun M, et al. Among authors: hartikainen p. Neuroimage Clin. 2019;22:101711. doi: 10.1016/j.nicl.2019.101711. Epub 2019 Feb 4. Neuroimage Clin. 2019. PMID: 30743135 Free PMC article.
Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis.
Niiranen M, Kontkanen A, Jääskeläinen O, Tertsunen HM, Selander T, Hartikainen P, Huber N, Solje E, Haapasalo A, Kokkola T, Lohioja T, Herukka SK, Simula S, Remes AM. Niiranen M, et al. Among authors: hartikainen p. Mult Scler Relat Disord. 2021 Nov;56:103280. doi: 10.1016/j.msard.2021.103280. Epub 2021 Sep 28. Mult Scler Relat Disord. 2021. PMID: 34627002
77 results